Streetbeat News

Stock Prices

QTTB

Q32 Bio shares are trading higher after Guggenheim initiated coverage with a Buy rating and a $100 price target.

Portfolio Pulse from Benzinga Newsdesk

June 17, 2024 | 11:43 am

AAN

Aarons Holdings shares are trading higher following the announcement of a definitive agreement to be acquired by IQVentures Holdings.

Portfolio Pulse from Benzinga Newsdesk

June 17, 2024 | 11:42 am

ABSI

ABVX

AMCX

EVO

GCI

HUMA

INFN

LPX

LRMR

Several major stocks, including AMC Networks, Louisiana-Pacific, and others, are experiencing declines in Monday's pre-market session. AMC Networks fell sharply due to a private offering of convertible senior notes, while Louisiana-Pacific was downgraded by Goldman Sachs.

Portfolio Pulse from Avi Kapoor

June 17, 2024 | 11:41 am

VERO

Venus Concept shares are trading higher following the announcement of a new strategic supply arrangement with Skin Laundry Holdings for resurfacing and skin tightening devices.

Portfolio Pulse from Benzinga Newsdesk

June 17, 2024 | 11:40 am

QGEN

QIAGEN has announced its commitment to deliver solid profitable growth through 2028, targeting a 7% compound annual sales growth (CAGR) at constant exchange rates (CER) and achieving at least a 31% CER adjusted operating income margin by 2028.

Portfolio Pulse from Benzinga Newsdesk

June 17, 2024 | 11:37 am

SHAK

Shake Shack has appointed Stephanie Sentell as the new Chief Operations Officer, effective July 1, 2024.

Portfolio Pulse from Benzinga Newsdesk

June 17, 2024 | 11:35 am

ADSK

LEN

LZB

QQQ

SPY

U.S. stocks are set for a cautious start after last week's record run, with mixed sentiment in index futures. Key focus areas include Fed speeches and manufacturing data. Tech stocks may continue to show strength, but broader market performance remains uncertain. Analysts suggest buying on dips and highlight the importance of falling Treasury yields and broader market rotation. Autodesk shares rose on news of an activist investor stake, while La-Z-Boy and Lennar are set to release quarterly results.

Portfolio Pulse from Shanthi Rexaline

June 17, 2024 | 11:35 am

OVID

Ovid Therapeutics shares are trading lower after Takeda's Skyline study in Dravet syndrome missed its primary endpoint.

Portfolio Pulse from Benzinga Newsdesk

June 17, 2024 | 11:35 am

MU

Micron shares are trading higher after B of A Securities raised its price target on the stock from $144 to $170.

Portfolio Pulse from Benzinga Newsdesk

June 17, 2024 | 11:33 am

NTLA

Intellia Therapeutics announced that an abstract featuring redosing data from the Phase 1 study of NTLA-2001 has been accepted for an oral presentation at the Peripheral Nerve Society Annual Meeting. NTLA-2001 is an investigational CRISPR-based gene editing therapy for transthyretin (ATTR) amyloidosis.

Portfolio Pulse from Benzinga Newsdesk

June 17, 2024 | 11:33 am